Skip to Content

Notice

Pulmonary-Allergy Drugs Advisory Committee; Cancellation

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Notice.

SUMMARY:

The Food and Drug Administration (FDA) is canceling the meeting of the Pulmonary-Allergy Drugs Advisory Committee scheduled for December 20, 2002. This meeting was announced in the Federal Register of November 13, 2002 (67 FR 68878).

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Kimberly L. Topper, Center for Drug Evaluation and Research (HFD-21), Food and Drug Administration, 5600 Fishers Lane (for express delivery, 5630 Fishers Lane, rm. 1093), Rockville, MD 20857, 301-827-7001, FAX 301-827-6776, or e-mail: topperk@cder.fda.gov, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 12545.

End Further Info Start Signature

Dated: December 16, 2002.

Linda Arey Skladany,

Associate Commissioner for External Relations.

End Signature End Preamble

[FR Doc. 02-32157 Filed 12-17-02; 3:05 pm]

BILLING CODE 4160-01-S